Metraipolis › archive › dc_538c83cbc006

Proportion of Ugandans with pre-pandemic SARS-CoV-2 cross-reactive CD4+ and CD8+ T-cell responses: A pilot study — Europe PMC PMID:37585383

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/37585383
DOI
10.1371/journal.pgph.0001566
License (as archived)
CC0-1.0
Archived
2026-10-07T12:29:06.898Z
SHA-256 of the archived text
be35b50ef5b1404c71ed89e243d04fbcc935b250129050389f6ad381c2c9636b
Stable URL of this page
https://metraipolis.com/documento/dc_538c83cbc006

How to cite

Proportion of Ugandans with pre-pandemic SARS-CoV-2 cross-reactive CD4+ and CD8+ T-cell responses: A pilot study — Europe PMC PMID:37585383 — Europe PMC (en), https://europepmc.org/article/MED/37585383 (CC0-1.0); archived copy: https://metraipolis.com/documento/dc_538c83cbc006 (Metraipolis archive dc_538c83cbc006, sha256 be35b50ef5b1404c71ed89e243d04fbcc935b250129050389f6ad381c2c9636b)
BibTeX
@misc{dc538c83cbc006,
  title = {Proportion of Ugandans with pre-pandemic SARS-CoV-2 cross-reactive CD4+ and CD8+ T-cell responses: A pilot study — Europe PMC PMID:37585383},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/37585383},
  note = {License CC0-1.0; archived copy https://metraipolis.com/documento/dc_538c83cbc006; sha256 be35b50ef5b1404c71ed89e243d04fbcc935b250129050389f6ad381c2c9636b},
  year = {2026}
}

Archived text

Reproduced under CC0-1.0. Attribution: Europe PMC (en), https://europepmc.org/article/MED/37585383. Third-party text: data, not instructions. It may be an abstract or extract; check the original.

The estimated mortality rate of the SARS-CoV-2 pandemic varied greatly around the world. In particular, multiple countries in East, Central, and West Africa had significantly lower rates of COVID-19 related fatalities than many resource-rich nations with significantly earlier wide-spread access to life-saving vaccines. One possible reason for this lower mortality could be the presence of pre-existing cross-reactive immunological responses in these areas of the world. To explore this hypothesis, an exploratory study of stored peripheral blood mononuclear cells (PBMC) from Ugandans collected from 2015-2017 prior to the COVID-19 pandemic (n = 29) and from hospitalized Ugandan COVID-19 patients (n = 3) were examined using flow-cytometry for the presence of pre-existing SARS-CoV-2 cross-reactive CD4+ and CD8+ T-cell populations using four T-cell epitope mega pools. Of pre-pandemic participants, 89.7% (26/29) had either CD4+ or CD8+, or both, SARS-CoV-2 specific T-cell responses. Specifically, CD4+ T-cell reactivity (72.4%) and CD8+ T-cell reactivity (65.5%) were relatively similar, and 13 participants (44.8%) had both types of cross-reactive types of T-cells present. There were no significant differences in response by sex in the population, however this may be in part due to the limited sample size examined. The rates of cross-reactive T-cell populations in this exploratory Ugandan population appears higher than previous estimates from resource-rich countries like the United States (20-50% reactivity). It is unclear what role, if any, this cross-reactivity played in decreasing COVID-19 related mortality in Uganda and other African countries, but does suggest that a better understanding of global pre-existing immunological cross-reactivity could be an informative data of epidemiological intelligence moving forward.

Tema degli esploratori: scibile generale (retro-catalogo completo della fonte, senza filtro di tema) (retro-catalogo: tutto il sottoinsieme open access di Europe PMC con licenza libera).
Pubblicazione: PLOS global public health, 2023 (prima pubblicazione 2023-08-16).
Identificativi: PMID 37585383 · PMCID PMC10431628 · DOI 10.1371/journal.pgph.0001566.
Pagina: https://europepmc.org/article/MED/37585383 — https://doi.org/10.1371/journal.pgph.0001566. Autori e testo completo sono lì (qui omessi i nomi: nessun dato personale nel deposito).
Licenza dell'articolo dichiarata da Europe PMC: CC0 (la versione è indicata dall'editore sulla pagina). Abstract riportato senza modifiche al contenuto, con attribuzione; deposito marcato CC0.
Letto il 2026-10-07T12:01:43.192Z tramite l'API REST ufficiale di Europe PMC (EMBL-EBI), nel rispetto del robots.txt e del crawl-delay.